Sequencing

Is Cabazitaxel Before Docetaxel The Future Way To Go? *

Chemotherapy for prostate cancer is still limited to just two drugs, docetaxel (Taxotere) and cabazitaxel (Jevtana). Both of these chemotherapy drugs are taxanes, but they seem to be very different in their mode of action. A study published online in Clinical Cancer Research, indicates that cabazitaxel might be more effective for some men than docetaxel. [...]

By Malecare|2020-02-04T11:15:45-05:00February 18th, 2015|Advanced Prostate Cancer, Cabazitaxel, docetaxel, Drugs & Treatments, Jevtana, Research, taxanes, taxotere, Uncategorized, Understanding APC|0 Comments

Looking Forward Towards the Future – Zytiga or Xtandi First After Provenge

What will happen when enzalutamide (Xtandi) is approved for use in advanced prostate cancer in the disease stage prior to chemotherapy (that is if it is approved)? Already occupying this space and already approved by the FDA is both Provenge and abiraterone (Zytiga). Where will Xtandi fit in? Until we have a lot more data, [...]

By Malecare|2017-10-19T10:48:08-04:00June 27th, 2014|2nd line hormone therapy, abiraterone acetate, Advanced Prostate Cancer, Drugs & Treatments, enzalutamide, Provenge, Uncategorized, Understanding APC, Xtandi, Zytiga|8 Comments